Sunrest Lifescience Limited IPO
Sunrest Lifescience Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹84 per share. The stock debuted at ₹84 with a flat listing performance. The IPO had a lot size of ₹1600 shares and a minimum investment of ₹1,34,400.
Sunrest Lifescience Limited IPO
- IPO Dates
- Nov 7, 2023 – Nov 9, 2023
- Price band
- ₹84 per equity share
- Minimum Investment
- ₹1,34,400
- Issue size
- 1,291,200 shares(aggregating up to ₹10.85 Cr)
- Lot size
- 1600
- Allotment Date
- Nov 15, 2023
- Listing
- Nov 20, 2023
- Listing At
- NSE SME
IPO timeline
-
Nov 7, 2023
Open Date
Completed
-
Nov 9, 2023
Close Date
Completed
-
Nov 15, 2023
Allotment Date
Completed
-
Nov 20, 2023
Listing Date
Completed
Sunrest Lifescience Limited IPO Essentials
Sunrest Lifescience Limited IPO Details
Sunrest Lifescience Limited IPO is priced at ₹84 per share with a total issue size of 1,291,200 shares(aggregating up to ₹10.85 Cr). The IPO has a lot size of 1600 shares and is listed on NSE SME.
- Issue price
- ₹84 per equity share
- Lot size
- 1600 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 1,291,200 shares(aggregating up to ₹10.85 Cr)
- Listing at
- NSE SME
- List price
- 84.0
- Listing date
- Registrar
- Skyline Financial Services Private Ltd
- Lead manager
-
Mark Corporate Advisors Private Limited
Sunrest Lifescience Limited IPO Analytics
Sunrest Lifescience Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sunrest Lifescience Limited IPO Subscription Status
Sunrest Lifescience Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 612,800 | 612,800 | 1,225,600 |
|
Day 1
07-11-23 06:00 PM
|
(0.62) x | 5.86 x | 3.24 x |
|
Day 2
08-11-23 06:00 PM
|
(2.67) x | 19.88 x | 11.28 x |
|
Day 3
09-11-23 06:00 PM
|
(29.17) x | 65.74 x | 48.54 x |
Sunrest Lifescience Limited Valuations
Earnings
- EPS (Post IPO)
- ₹6.81/-
- P/E Ratio
- 12.33
Returns
- RoNW
- 65.59%
Sunrest Lifescience Limited Financials( In Lakhs)
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Assets | 1,671.37 | 1,301.97 | 948.15 |
| Revenue | 2,467.05 | 2,690.99 | 1,694.91 |
| Profit After Tax | 204.31 | 77.71 | 16.55 |
Sunrest Lifescience Limited Company & Offer Insights
About Sunrest Lifescience Limited
Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Sunrest Lifescience Limited Promoter(s)
Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar. are the company's promoters of Sunrest Lifescience Limited.
Sunrest Lifescience Limited IPO Issue Objectives
- •
- Meeting Working Capital Requirements
- •
- General Corporate Purpose
- •
- Meeting Public Issue Expenses
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Sunrest Lifescience Limited IPO is a Fixed Priced IPO worth ₹1,291,200 shares(aggregating up to ₹10.85 Cr). The issue price is ₹84 per share (fixed price). The IPO opens on Nov 7, 2023 and closes on Nov 9, 2023. It will be listed on NSE SME Platform. Skyline Financial Services Private Ltd is the registrar.
The issue price of Sunrest Lifescience Limited IPO is ₹84 per share (fixed price).
The lot size of Sunrest Lifescience Limited IPO is 1600 shares.
The minimum investment for Sunrest Lifescience Limited IPO is approximately ₹1,34,400 based on the issue price .
Sunrest Lifescience Limited IPO opens on Nov 7, 2023 and closes on Nov 9, 2023.
The allotment date of Sunrest Lifescience Limited IPO is Nov 15, 2023.
Sunrest Lifescience Limited IPO is expected to be listed on Nov 20, 2023, on NSE SME Platform.
Sunrest Lifescience Limited IPO valuation snapshot: P/E 12.33, EPS ₹6.81/-, P/B N/A, RoNW 65.59%, and market cap N/A.
To apply for Sunrest Lifescience Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sunrest Lifescience Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sunrest Lifescience Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sunrest Lifescience Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sunrest Lifescience Limited IPO allotment status on IPO Ji for quick and easy access.